NBIX

NASDAQ · Equity

Neurocrine Biosciences Inc

US Healthcare Drug Manufacturers - Specialty & Generic

Latest week
29 May 2026
Close
158.300000
Fair value
128.088814
Expectation
Positive 55.97%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
158.30
12-Week Change
21.98%
Trend Signal
Inactive
Expectation
Positive 55.97%
Signal Weeks
0 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
-6.13
Market Dynamics
1.29

Over the latest 12 completed weeks ending 2026-05-29, NBIX rose 21.98%, moving from 129.78 to 158.30. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -6.13 and has softened across the 12-week window. Market Dynamics is 1.29 on the latest week. Expectation is positive at 55.97%.